Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitigation of Dimethyl Fumarate GI Symptoms in MS
NCT02217982Phase 4Terminated
- Sponsor
- Rocky Mountain MS Research Group
- Start
- Jul 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of simethicone, loperamide, sponsored by Rocky Mountain MS Research Group. Started Jul 2014; status: terminated.
02
Drugs
simethiconeloperamide
Beyond the preview
Go deeper on NCT02217982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02217982.